Ken Griffin Illumina, Inc. Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$101.05 - $133.57 $545,670 - $721,278	5,400 Added 3.19%	174,700 $18.2 Million
Q1 2024 May 15, 2024	SELL	$127.73 - $147.2 $14.2 Million - $16.4 Million	-111,400 Reduced 39.69%	169,300 $23.2 Million
Q4 2023 Feb 14, 2024	BUY	$92.79 - $142.53 $15 Million - $23.1 Million	161,900 Added 136.28%	280,700 $39.1 Million
Q3 2023 Nov 14, 2023	SELL	$128.91 - $192.44 $8.78 Million - $13.1 Million	-68,100 Reduced 36.44%	118,800 $16.3 Million
Q2 2023 Aug 14, 2023	SELL	$183.43 - $232.67 $7.72 Million - $9.8 Million	-42,100 Reduced 18.38%	186,900 $35 Million
Q1 2023 May 15, 2023	SELL	$193.75 - $232.55 $2.03 Million - $2.44 Million	-10,500 Reduced 4.38%	229,000 $53.3 Million
Q4 2022 Feb 14, 2023	SELL	$187.24 - $242.74 $50.7 Million - $65.7 Million	-270,700 Reduced 53.06%	239,500 $48.4 Million
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $33.7 Million - $43.2 Million	190,000 Added 59.34%	510,200 $97.3 Million

896

137M

1.43M

1.62M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $23B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.